AI辅助肺功能解读提升间质性肺疾病诊断准确性
本研究评估AI软件(ArtiQ.PFT)辅助呼吸科医生解读肺功能对间质性肺疾病(ILD)诊断的影响。研究分两阶段:第一阶段25名医生对60例患者(30例ILD)在无AI和有AI辅助下分别诊断;第二阶段19名医生使用AI 4-6个月后重复方案。结果显示AI将多种肺病诊断准确率从41.8%提升至62.3%,ILD作为主要诊断的检出率从42.8%升至72.1%(p<0.0001),第二阶段从53.2%升至75.1%(p<0.0001)。
要点
- AI辅助肺功能解读可将ILD主要诊断检出率从42.8%提升至72.1%。
- 使用AI 4-6个月后,ILD诊断准确率仍从53.2%提升至75.1%。
- 无AI辅助时ILD检出率在两阶段间有显著提升(p=0.028),有AI时无显著差异(p=0.24)。
核心结论
- 基于AI的肺功能解读决策支持可提高ILD诊断的准确性和早期诊断能力。
研究设计与样本
- 研究分两阶段:第一阶段60例患者(30例ILD),25名呼吸科医生(8名初级、17名经验丰富)在无AI和有AI辅助下分别诊断。
- 第二阶段19名呼吸科医生使用AI软件4-6个月后重复相同诊断方案。
主要发现
- 第一阶段AI将多种肺病诊断准确率从41.8%提升至62.3%。
- 第一阶段ILD作为主要诊断的检出率从42.8%升至72.1%(p<0.0001)。
- 第二阶段使用AI后ILD主要诊断检出率从53.2%升至75.1%(p<0.0001)。
- 无AI辅助时ILD检出率在兩阶段间显著增加(p=0.028),有AI辅助时无显著差异(p=0.24)。
临床怎么用
- 呼吸科医生在解读肺功能时可借助AI软件(如ArtiQ.PFT)提高ILD诊断准确性。
- AI辅助有助于早期识别肺纤维化,可作为肺功能解读的决策支持工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The diagnosis of interstitial lung disease (ILD) can pose a challenge as the pulmonary function test (PFT) is only minimally affected at the onset. To improve early diagnosis, this study aims to explore the potential of artificial intelligence (AI) software in assisting pulmonologists with PFT interpretation for ILD diagnosis. The software provides an automated description of PFT and disease probabilities computed from an AI model. STUDY METHODS: In study phase 1, a cohort of 60 patients, 30 of whom had ILD, were retrospectively diagnosed by 25 pulmonologists (8 junior physicians and 17 experienced pneumologists) by evaluating a PFT (body plethysmography and diffusion capacity) and a short medical history. The experts screened the cohort twice, without and with the aid of AI (ArtiQ.PFT, V.1.4.0, ArtiQ, BE) software and provided a primary diagnosis and up to three differential diagnoses for each case. In study phase 2, 19 pulmonologists repeated the protocol after using ArtiQ.PFT for 4-6 months. RESULTS: Overall, AI increased the diagnostic accuracy for various lung diseases from 41.8% to 62.3% in study phase 1. Focusing on ILD, AI improved the detection of lung fibrosis as the primary diagnosis from 42.8% without AI to 72.1% with AI (p<0.0001). Phase 2 yielded a similar outcome: using AI increased ILD diagnosis based on primary diagnosis (53.2% to 75.1%; p<0.0001). ILD detections without AI support significantly increased between phase 1 and phase 2 (p=0.028) but not with AI (p=0.24). INTERPRETATION: This study shows that AI-based decision support on PFT interpretation improves accurate and early ILD diagnosis.
引用
- Gompelmann D, Gysan MR, Desbordes P, et al. AI-powered evaluation of lung function for diagnosis of interstitial lung disease. Thorax. 2025. PMID: 40081903. doi:10.1136/thorax-2024-221537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。